Co-Authors
This is a "connection" page, showing publications co-authored by Michael von Bergwelt-Baildon and Daniel Duerschmied.
Connection Strength
0.059
-
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial. Lancet Respir Med. 2021 08; 9(8):863-872.
Score: 0.059
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.